E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8
E11	Condition:T11 Name:T12 Severity:T107 Acuteness:T108 Acuteness:T109
E13	Condition:T13 Name:T14
E15	Observation:T15 Name:T16 Numeric-Filter:E6
E17	Condition:T17 Name:T18
E19	Condition:T19 Name:T20
E21	Condition:T21 Name:T22
E23	Condition:T23 Name:T24
E25	Condition:T25 
E27	Condition:T27 Name:T28
E29	Condition:T29 Name:T30
E32	Condition:T32 Name:T33
E34	Condition:T34 Name:T35
E36	Condition:T36 Name:T37 Stage:E14 Stage2:E16
E38	Condition:T38 Name:T39
E39	Age:T44 Numeric-Filter:E4
E40	Eq-Comparison:T50 Operator:T40 Value:T47 Unit:T65
E4	Eq-Comparison:T53 Temporal-Unit:T41 Operator:T54 Value:T45
E6	Eq-Comparison:T55 Unit:T57 Operator:T56 Value:T46
E8	Condition:T58 Name:T59
E10	Observation:T60 Name:T61 Polarity:T62
E12	Observation:T63 Name:T64 Numeric-Filter:E40
E20	Condition:T69 Name:T70
E22	Assertion:T71 Asserted:E26
E24	Observation:T72 Stability:T118
E26	Negation:T73 Negates:T118
E9	Drug:T9 Name:T10 Temporality:E33
E30	Drug:T75 Name:T76
E31	Drug:T77 Name:T78
E33	Eq-Comparison:T79 Temporal-Unit:T42 Value:T48
E35	Study:T80 
E41	Condition:T82 
E42	Assertion:T83 Asserted:E43
E43	Condition:T84 Name:T85
E44	Condition:T86 Name:T87
E46	Procedure:T89 Name:T90 Temporality:E47
E47	Eq-Comparison:T91 Temporal-Unit:T43 Value:T49
E48	Study:T92 
E50	Condition:T94 Name:T95
E51	Condition:T96 Name:T97
E52	Assertion:T98 Asserted:E51
E53	Condition:T99 Name:T100
E55	Procedure:T102 Name:T103 Temporality:E64
E56	Condition:T104 
E14	Eq-Comparison:T66 Unit:T67 Value:T68
E16	Eq-Comparison:T111 Unit:T112 Value:T113
E61	Modifier:T115 Modifies:T35
E62	Modifier:T116 Modifies:T2
E63	Modifier:T117 Modifies:T6
E64	Eq-Comparison:T119 Temporal-Period:T120
T1	Condition 338 358	macular degeneration
T2	Condition-Name 338 358	macular degeneration
T3	Condition 801 829	systemic lupus erythematosus
T4	Condition-Name 801 829	systemic lupus erythematosus
T5	Condition 259 267	glaucoma
T6	Condition-Name 259 267	glaucoma
T7	Condition 523 542	Ocular inflammation
T8	Condition-Name 523 542	Ocular inflammation
T11	Condition 1122 1137	organic disease
T12	Condition-Name 1122 1137	organic disease
T13	Condition 547 561	ocular disease
T14	Condition-Name 547 561	ocular disease
T15	Observation 97 106	ametropia
T16	Observation-Name 97 106	ametropia
T17	Condition 835 844	Porphyria
T18	Condition-Name 835 844	Porphyria
T19	Condition 846 854	Vitiligo
T20	Condition-Name 846 854	Vitiligo
T21	Condition 882 890	Albinism
T22	Condition-Name 882 890	Albinism
T23	Condition 920 928	epilepsy
T24	Condition-Name 920 928	epilepsy
T25	Condition 1070 1078	disorder
T27	Condition 278 282	POAG
T28	Condition-Name 278 282	POAG
T29	Condition 300 304	POAG
T30	Condition-Name 300 304	POAG
T31	Life-Stage-And-Gender 25 28	men
T32	Condition 360 363	AMD
T33	Condition-Name 360 363	AMD
T34	Condition 385 388	AMD
T35	Condition-Name 385 388	AMD
T36	Condition 426 429	AMD
T37	Condition-Name 426 429	AMD
T38	Condition 830 833	SLE
T39	Condition-Name 830 833	SLE
T40	Eq-Operator 313 315	<=
T41	Eq-Temporal-Unit 52 57	years
T42	Eq-Temporal-Unit 683 689	months
T43	Eq-Temporal-Unit 958 964	months
T44	Age 39 43	aged
T45	Eq-Value 49 51	18
T46	Eq-Value 113 114	3
T47	Eq-Value 316 318	10
T48	Eq-Value 681 682	3
T49	Eq-Value 956 957	3
T50	Eq-Comparison 313 321	<= 10 dB
T51	Life-Stage-And-Gender 33 38	women
T53	Eq-Comparison 44 57	over 18 years
T54	Eq-Operator 44 48	over
T55	Eq-Comparison 107 123	below 3 diopters
T56	Eq-Operator 107 112	below
T57	Eq-Unit 115 123	diopters
T58	Condition 180 187	healthy
T59	Condition-Name 180 187	healthy
T60	Observation 212 235	ophthalmologic findings
T61	Observation-Name 212 235	ophthalmologic findings
T62	Polarity 205 211	normal
T63	Observation 310 312	MD
T64	Observation-Name 310 312	MD
T65	Eq-Unit 319 321	dB
T69	Condition 471 484	abnormalities
T70	Condition-Name 471 484	abnormalities
T71	Assertion 485 495	preventing
T72	Observation 505 517	measurements
T73	Negation 485 495	preventing
T9	Drug 606 633	photosensitizing medication
T10	Drug-Name 606 633	photosensitizing medication
T75	Drug 635 651	phototoxic drugs
T76	Drug-Name 635 651	phototoxic drugs
T77	Drug 653 672	photoallergic drugs
T78	Drug-Name 653 672	photoallergic drugs
T79	Eq-Comparison 681 689	3 months
T80	Study 704 709	study
T82	Condition 731 740	condition
T83	Assertion 750 764	possibility of
T84	Condition 773 789	photosensitivity
T85	Condition-Name 773 789	photosensitivity
T86	Condition 856 877	Xeroderma Pigmentosum
T87	Condition-Name 856 877	Xeroderma Pigmentosum
T89	Procedure 934 948	Ocular surgery
T90	Procedure-Name 934 948	Ocular surgery
T91	Eq-Comparison 956 964	3 months
T92	Study 979 984	study
T94	Condition 990 999	Pregnancy
T95	Condition-Name 990 999	Pregnancy
T96	Condition 1009 1018	pregnancy
T97	Condition-Name 1009 1018	pregnancy
T98	Assertion 1001 1008	planned
T99	Condition 1022 1031	lactating
T100	Condition-Name 1022 1031	lactating
T102	Procedure 1052 1060	surgical
T103	Procedure-Name 1052 1060	surgical
T104	Condition 1082 1089	disease
T107	Severity 1115 1121	severe
T109	Acuteness 1107 1114	chronic
T66	Eq-Comparison 416 425	stage III
T67	Eq-Unit 416 421	stage
T68	Eq-Value 422 425	III
T111	Eq-Comparison 404 412	stage II
T112	Eq-Unit 404 409	stage
T113	Eq-Value 410 412	II
T115	Modifier 381 384	dry
T116	Modifier 326 337	age-related
T117	Modifier 240 258	primary open angle
T118	Stability 496 504	reliable
T119	Eq-Comparison 1061 1068	history
T120	Eq-Temporal-Period 1061 1068	history
T108	Acuteness 1098 1103	acute
A1	Eq-Operator-Value T40 LTEQ
A2	Eq-Temporal-Unit-Value T41 year
A3	Eq-Temporal-Unit-Value T42 month
A4	Eq-Temporal-Unit-Value T43 month
A5	Life-Stage-And-Gender-Type T31 male
A6	Life-Stage-And-Gender-Type T51 female
A7	Eq-Operator-Value T54 GT
A8	Eq-Operator-Value T56 LT
A9	Polarity-Value T62 normal
A10	Assertion-Type-Value E22 hypothetical
A12	Assertion-Type-Value E42 possible
A14	Assertion-Type-Value E52 intention
A15	Severity-Value T107 severe
A16	Stability-Value T118 stable
A17	Eq-Temporal-Period-Value T120 past
A19	Acuteness-Type-Value T108 acute
A20	Acuteness-Type-Value T109 chronic
R1	Abbrev-Of Arg1:E27 Arg2:E5
R2	Abbrev-Of Arg1:E32 Arg2:E1
R3	Caused-By Arg1:E26 Arg2:E20
R4	Example-Of Arg1:E30 Arg2:E9
R5	Example-Of Arg1:E31 Arg2:E9
R6	Caused-By Arg1:E43 Arg2:E41
R7	Example-Of Arg1:E3 Arg2:E41
R8	Example-Of Arg1:E38 Arg2:E41
R9	Example-Of Arg1:E17 Arg2:E41
R10	Example-Of Arg1:E19 Arg2:E41
R11	Example-Of Arg1:E44 Arg2:E41
R12	Example-Of Arg1:E21 Arg2:E41
R13	Example-Of Arg1:E11 Arg2:E56
R14	Or Arg1:T31 Arg2:T51
R15	Or Arg1:E7 Arg2:E13
R16	Before Arg1:E33 Arg2:E35
R17	Or Arg1:E44 Arg2:E21
R18	Before Arg1:E47 Arg2:E48
R19	Or Arg1:E51 Arg2:E53
R20	Or Arg1:E25 Arg2:E56
R21	Or Arg1:T108 Arg2:T109
R22	Or Arg1:E16 Arg2:E14
R23	Or Arg1:E17 Arg2:E19
R24	Or Arg1:E19 Arg2:E44
R25	Or Arg1:E38 Arg2:E17
R26	Or Arg1:E30 Arg2:E31
R27	Example-Of Arg1:E25 Arg2:E11	
